We will be a partner in the planned ANeED Study, headed by Associate Professor Arvid Rongve at Helse Fonna.  This is a phase IIa multicentre randomized controlled double blind clinical trial to demonstrate clinical efficacy on cognitive, neuropsychiatric and functional outcomes of Ambroxol in New and Early patients with prodromal and mild Dementia with Lewy bodies.